Invention Grant
- Patent Title: Cytotoxic agents comprising new taxanes
- Patent Title (中): 包含新紫杉烷的细胞毒剂
-
Application No.: US11295294Application Date: 2005-12-06
-
Publication No.: US07667054B2Publication Date: 2010-02-23
- Inventor: Michael L. Miller , Ravi V. J. Chari , Erkan Baloglu , Alain Commercon
- Applicant: Michael L. Miller , Ravi V. J. Chari , Erkan Baloglu , Alain Commercon
- Applicant Address: FR Antony
- Assignee: Aventis Pharma S.A.
- Current Assignee: Aventis Pharma S.A.
- Current Assignee Address: FR Antony
- Agent Paul R. Darkes
- Priority: EP04292898 20041207
- Main IPC: C07D305/00
- IPC: C07D305/00
Abstract:
The invention relates to novel cytotoxic agents comprising taxanes and their therapeutic use as a result of delivering the taxanes to a specific cell population in a targeted fashion by chemically linking the taxane to a cell binding agent.
Public/Granted literature
- US20060178427A1 Cytotoxic agents comprising new taxanes Public/Granted day:2006-08-10
Information query
